Disclaimer: The TipRanks Smart Score performance is based on backtested results. Backtested performance is not an indicator of future actual results. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. Backtested results are calculated by the retroactive application of a model constructed on the basis of historical data and based on assumptions integral to the model which may or may not be testable and are subject to losses. General assumptions include: XYZ firm would have been able to purchase the securities recommended by the model and the markets were sufficiently liquid to permit all trading. Changes in these assumptions may have a material impact on the backtested returns presented. Certain assumptions have been made for modeling purposes and are unlikely to be realized. No representations and warranties are made as to the reasonableness of the assumptions. This information is provided for illustrative purposes only. Backtested performance is developed with the benefit of hindsight and has inherent limitations. Specifically, backtested results do not reflect actual trading or the effect of material economic and market factors on the decision-making process. Since trades have not actually been executed, results may have under- or over-compensated for the impact, if any, of certain market factors, such as lack of liquidity, and may not reflect the impact that certain economic or market factors may have had on the decision-making process. Further, backtesting allows the security selection methodology to be adjusted until past returns are maximized. Actual performance may differ significantly from backtested performance. Backtested results are adjusted to reflect the reinvestment of dividends and other income and, except where otherwise indicated, are presented gross-of fees and do not include the effect of backtested transaction costs, management fees, performance fees or expenses, if applicable. Please note all regulatory considerations regarding the presentation of fees must be taken into account. No cash balance or cash flow is included in the calculation.
FAQs
AbbVie (ABBV) Stock Forecast, Price Targets and Analysts Predictions - TipRanks.com? ›
ABBV Stock 12 Month Forecast
What is the target price for AbbVie stock? ›| Average Recommendation | Overweight |
|---|---|
| Average Target Price | 184.29 |
| Number Of Ratings | 29 |
| FY Report Date | 12/2024 |
| Last Quarter's Earnings | 2.79 |
Stock Price Forecast
The 11 analysts with 12-month price forecasts for AbbVie stock have an average target of 182.18, with a low estimate of 150 and a high estimate of 196. The average target predicts an increase of 12.46% from the current stock price of 162.00.
Is AbbVie stock a Buy, Sell or Hold? AbbVie stock has received a consensus rating of buy. The average rating score is and is based on 35 buy ratings, 8 hold ratings, and 3 sell ratings.
What is the future price of AbbVie stock? ›Based on short-term price targets offered by 19 analysts, the average price target for AbbVie comes to $179.37. The forecasts range from a low of $150.00 to a high of $196.00. The average price target represents an increase of 7.07% from the last closing price of $167.52.
What is AbbVie stock price prediction for 2024? ›AbbVie Stock Price Forecast 2024-2025
AbbVie price started in 2024 at $154.97. Today, AbbVie traded at $174.08, so the price increased by 12% from the beginning of the year. The forecasted AbbVie price at the end of 2024 is $221 - and the year to year change +43%. The rise from today to year-end: +27%.
Abbvie Inc quote is equal to 166.410 USD at 2024-04-20. Based on our forecasts, a long-term increase is expected, the "ABBV" stock price prognosis for 2029-04-11 is 235.704 USD. With a 5-year investment, the revenue is expected to be around +41.64%. Your current $100 investment may be up to $141.64 in 2029.
What is AbbVie stock price prediction for 2025? ›The Abbvie stock forecast for 2025 had the price at $259.018.
What is the stock forecast for ABT in 2025? ›Abbott Laboratories stock prediction for 1 year from now: $ 127.14 (20.90%) Abbott Laboratories stock forecast for 2025: $ 118.01 (11.81%) Abbott Laboratories stock prediction for 2030: $ 206.19 (95.35%)
Is AbbVie a monthly dividend? ›( ABBV ) pays dividends on a quarterly basis. The next dividend payment is planned on May 15, 2024 . AbbVie Inc. ( ABBV ) has increased its dividends for 10 consecutive years.
Is AbbVie a good long term stock? ›
In terms of dividend growth, the company's current annualized dividend of $6.20 is up 4.7% from last year. In the past five-year period, AbbVie has increased its dividend 5 times on a year-over-year basis for an average annual increase of 8.28%.
Is ABBV a safe stock? ›The company is still going strong. It currently offers a yield of 3.55%, and its cash payout ratio remains conservative at 42.13%. That leaves ample room for more dividend hikes. Here's the bottom line: Whether for growth or dividends, AbbVie is still an excellent stock to buy.
Is ABBV a good dividend stock? ›Income investors must be conscious of the fact that high-yielding stocks tend to struggle during periods of rising interest rates. With that in mind, ABBV is a compelling investment opportunity. Not only is it a strong dividend play, but the stock currently sits at a Zacks Rank of 3 (Hold).
What is AbbVie's long term outlook? ›AbbVie is forecast to grow earnings and revenue by 22.7% and 5.2% per annum respectively. EPS is expected to grow by 23.1% per annum. Return on equity is forecast to be 167% in 3 years.
Who is AbbVie buying? ›NORTH CHICAGO, Ill., Feb. 12, 2024 /PRNewswire/ -- AbbVie (NYSE: ABBV) announced today that it has completed its acquisition of ImmunoGen (NASDAQ: IMGN).
How much did AbbVie stock cost in 2013? ›The stock debuted on Jan. 2, 2013, as a spin-off from Abbott Labs, and it was priced at $35. If you'd invested $25,000 into the company then, that would have secured you about 714 shares of the healthcare business.
How many times a year does AbbVie pay dividends? ›( ABBV ) pays dividends on a quarterly basis. The next dividend payment is planned on May 15, 2024 . AbbVie Inc. ( ABBV ) has increased its dividends for 10 consecutive years.
What is Abbott stock prediction for 2025? ›Abbott Laboratories stock prediction for 1 year from now: $ 122.89 (14.53%) Abbott Laboratories stock forecast for 2025: $ 119.97 (11.81%) Abbott Laboratories stock prediction for 2030: $ 209.61 (95.35%)
What is a target price in stocks? ›A price target is an analyst's projection of a security's future price, one at which an analyst believes a stock is fairly valued. Analysts consider numerous fundamental and technical factors to arrive at a price target.